InfuSystem director receives 24,890 stock options

InfuSystem Holdings director Beverly A. Huss reported an equity compensation grant.

Accepted by SEC EDGAR 05/14/2026 - 06:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

InfuSystem Holdings director Beverly A. Huss reported an equity compensation grant. She received a stock option for 24,890 shares of common stock, with an exercise price of $8.37 per share. The option vests on May 12, 2027 and expires on May 12, 2036.

Following this grant, Huss holds 4,300 shares of common stock directly, along with the newly awarded options for 24,890 underlying shares. The filing reflects a compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 24,890 shares

Grant/Award 1 txn

Insider HUSS BEVERLY A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	24,890	$0.00	$0.00
Holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 24,890 contracts (Direct); Common Stock — 4,300 shares (Direct)

Footnotes (1)

1. F1. The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.

Key Figures

Option grant size: 24,890 shares Exercise price: $8.37 per share Vesting date: May 12, 2027 +2 more

5 metrics

Option grant size 24,890 shares Stock Option (right to buy) underlying common stock

Exercise price $8.37 per share Conversion or exercise price of option

Vesting date May 12, 2027 Option vests on this date

Expiration date May 12, 2036 Option expires on this date

Common shares held 4,300 shares Total common stock following transaction, direct ownership

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, exercise price, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

exercise price financial

"conversion_or_exercise_price: "8.3700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests on May 12, 2027 financial

"The option ... vests on May 12, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did InfuSystem (INFU) report for Beverly A. Huss?

InfuSystem reported that director Beverly A. Huss received a stock option grant for 24,890 shares. The option is a compensation award, not a market purchase or sale, and gives her the right to buy common stock at a fixed exercise price.

How many InfuSystem (INFU) shares are covered by Beverly Huss’s new option grant?

The new option grant covers 24,890 shares of InfuSystem common stock. These options give her the right to acquire that number of shares if exercised, subject to vesting and the stated exercise and expiration terms in the filing.

What is the exercise price of Beverly Huss’s InfuSystem (INFU) stock options?

The exercise price of Beverly Huss’s stock options is $8.37 per share. This means she can buy InfuSystem common stock at $8.37 once the option is vested and exercised, regardless of the market price at that future time.

When do Beverly Huss’s InfuSystem (INFU) stock options vest and expire?

The stock options granted to Beverly Huss vest on May 12, 2027 and expire on May 12, 2036. She generally cannot exercise them before vesting, and loses the right to exercise after the expiration date disclosed in the filing.

How many InfuSystem (INFU) shares does Beverly Huss own after this filing?

After this filing, Beverly Huss directly owns 4,300 shares of InfuSystem common stock. In addition, she holds options for 24,890 underlying shares, which represent potential future ownership if she chooses to exercise the options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HUSS BEVERLY A

(Last) (First) (Middle)

C/O INFUSYSTEM HOLDINGS, INC.

3851 WEST HAMLIN ROAD

(Street)

ROCHESTER HILLS MICHIGAN 48309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InfuSystem Holdings, Inc [ INFU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								4,300	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.37	05/12/2026		A		24,890		05/12/2027(1)	05/12/2036	Common Stock	24,890	$0	24,890	D

Explanation of Responses:

1. The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.

Remarks:

	/s/ Kevin Whitman, Attorney-in-Fact for Beverly A. Huss	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)